- This topic has 0 replies, 1 voice, and was last updated 1 year ago by
.
Viewing 0 reply threads
-
Posts
-
-
Spiriva® Respimat® (tiotropium)
is now indicated for add-on maintenance bronchodilator treatment in adults with asthma currently treated,
with inhaled corticosteroids (at least 800 microgram daily of budesonide or equivalent) and long-acting ?2agonists and
who experienced one or more severe exacerbations in the previous year.
The soft-mist inhaler is already licensed for maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD).
Do request if more info needed on this drug.
G Mohan.
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.